BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 38069167)

  • 1. Cell Therapy in the Treatment of Coronary Heart Disease.
    Chepeleva EV
    Int J Mol Sci; 2023 Nov; 24(23):. PubMed ID: 38069167
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Significance of a coronary artery with thrombolysis in myocardial infarction grade 2 flow "patency" (outcome in the thrombolysis and angioplasty in myocardial infarction trials). Thrombolysis and Angioplasty in Myocardial Infarction Study Group.
    Lincoff AM; Topol EJ; Califf RM; Sigmon KN; Lee KL; Ohman EM; Rosenschein U; Ellis SG
    Am J Cardiol; 1995 May; 75(14):871-6. PubMed ID: 7732992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Signalling pathways in ischaemic postconditioning.
    Hausenloy DJ
    Thromb Haemost; 2009 Apr; 101(4):626-34. PubMed ID: 19350104
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determinants of cardiac failure after coronary bypass surgery within 30 days of acute myocardial infarction.
    Katz NM; Kubanick TE; Ahmed SW; Green CE; Pearle DL; Satler LF; Rackley CE; Wallace RB
    Ann Thorac Surg; 1986 Dec; 42(6):658-63. PubMed ID: 3098199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reperfusion and revascularization strategies for coronary artery disease in women.
    Eysmann SB; Douglas PS
    JAMA; 1992 Oct; 268(14):1903-7. PubMed ID: 1404716
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipid lowering versus revascularization: an idea whose time (for testing) has come.
    Forrester JS; Shah PK
    Circulation; 1997 Aug; 96(4):1360-2. PubMed ID: 9286970
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Revascularization therapy for coronary artery disease. Coronary artery bypass grafting versus percutaneous transluminal coronary angioplasty.
    Wilson JM; Ferguson JJ
    Tex Heart Inst J; 1995; 22(2):145-61. PubMed ID: 7647598
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hospital disposition and long-term follow-up of patients aged >/=80 years undergoing coronary artery revascularization.
    Garza JJ; Gantt DS; Van Cleave H; Riggs MW; Dehmer GJ
    Am J Cardiol; 2003 Sep; 92(5):590-2. PubMed ID: 12943882
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Late-onset heart failure as a mechanism for adverse long-term outcome in diabetic patients undergoing revascularization (a 13-year report from the Lady Davis Carmel Medical Center registry).
    Halon DA; Merdler A; Flugelman MY; Rennert HS; Weisz G; Shahla J; Lewis BS
    Am J Cardiol; 2000 Jun; 85(12):1420-6. PubMed ID: 10856386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Argentine randomized trial of percutaneous transluminal coronary angioplasty versus coronary artery bypass surgery in multivessel disease (ERACI): in-hospital results and 1-year follow-up. ERACI Group.
    Rodriguez A; Boullon F; Perez-Baliño N; Paviotti C; Liprandi MI; Palacios IF
    J Am Coll Cardiol; 1993 Oct; 22(4):1060-7. PubMed ID: 8409041
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of coronary angioplasty and coronary artery bypass grafting outcomes in chronic dialysis patients.
    Rinehart AL; Herzog CA; Collins AJ; Flack JM; Ma JZ; Opsahl JA
    Am J Kidney Dis; 1995 Feb; 25(2):281-90. PubMed ID: 7847356
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Bypass Angioplasty Revascularization Investigation 2 Diabetes randomized trial of different treatment strategies in type 2 diabetes mellitus with stable ischemic heart disease: impact of treatment strategy on cardiac mortality and myocardial infarction.
    Chaitman BR; Hardison RM; Adler D; Gebhart S; Grogan M; Ocampo S; Sopko G; Ramires JA; Schneider D; Frye RL;
    Circulation; 2009 Dec; 120(25):2529-40. PubMed ID: 19920001
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is traditionally defined complete revascularization needed for patients with multivessel disease treated by elective coronary angioplasty? Multivessel Angioplasty Prognosis Study (MAPS) Group.
    Cowley MJ; Vandermael M; Topol EJ; Whitlow PL; Dean LS; Bulle TM; Ellis SG
    J Am Coll Cardiol; 1993 Nov; 22(5):1289-97. PubMed ID: 8227782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of previous coronary-artery bypass surgery on the prognosis of patients with diabetes who have acute myocardial infarction. Bypass Angioplasty Revascularization Investigation Investigators.
    Detre KM; Lombardero MS; Brooks MM; Hardison RM; Holubkov R; Sopko G; Frye RL; Chaitman BR
    N Engl J Med; 2000 Apr; 342(14):989-97. PubMed ID: 10749960
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The management of the cardiac patient requiring noncardiac surgery. Preoperative evaluation and management of the surgical patient with heart disease.
    Hermanovich J
    Surg Clin North Am; 1983 Oct; 63(5):985-91. PubMed ID: 6356421
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reperfusion therapy in cardiogenic shock complicating acute myocardial infarction.
    Santoro GM; Buonamici P
    Am Heart J; 1999 Aug; 138(2 Pt 2):S126-31. PubMed ID: 10426871
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and efficacy of direct cardiac shockwave therapy in patients with ischemic cardiomyopathy undergoing coronary artery bypass grafting (the CAST-HF trial): study protocol for a randomized controlled trial-an update.
    Nägele F; Pölzl L; Graber M; Hirsch J; Mayr A; Pamminger M; Troger F; Theurl M; Schreinlechner M; Sappler N; Dorfmüller C; Mitrovic M; Ulmer H; Grimm M; Gollmann-Tepeköylü C; Holfeld J
    Trials; 2022 Dec; 23(1):988. PubMed ID: 36494706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myocardial perfusion imaging for evaluating interventions in coronary artery disease.
    Newhouse HK; Wexler JP
    Semin Nucl Med; 1995 Jan; 25(1):15-27. PubMed ID: 7716554
    [TBL] [Abstract][Full Text] [Related]  

  • 19. API expert consensus document on management of ischemic heart disease.
    Association of Physicians of India
    J Assoc Physicians India; 2006 Jun; 54():469-80. PubMed ID: 16909697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LateTIME: a phase-II, randomized, double-blinded, placebo-controlled, pilot trial evaluating the safety and effect of administration of bone marrow mononuclear cells 2 to 3 weeks after acute myocardial infarction.
    Traverse JH; Henry TD; Vaughan DE; Ellis SG; Pepine CJ; Willerson JT; Zhao DX; Simpson LM; Penn MS; Byrne BJ; Perin EC; Gee AP; Hatzopoulos AK; McKenna DH; Forder JR; Taylor DA; Cogle CR; Baraniuk S; Olson RE; Jorgenson BC; Sayre SL; Vojvodic RW; Gordon DJ; Skarlatos SI; Moyè LA; Simari RD;
    Tex Heart Inst J; 2010; 37(4):412-20. PubMed ID: 20844613
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.